Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
Gabriele Picco(Wellcome Sanger Institute), Mathew J. Garnett(Wellcome Sanger Institute)
Cited by 48
Related Papers
Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics
|Nature Communications|2018|335
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
|Cancer Discovery|2021|113
A suspension technique for efficient large-scale cancer organoid culturing and perturbation screens
|Scientific Reports|2022|42
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations
|Cancer Discovery|2024|35